Equity Overview
Price & Market Data
Price: $4.47
Daily Change: $0.00 / 0.00%
Daily Range: $3.89 - $4.72
Market Cap: $232,079,344
Daily Volume: 111,210
Performance Metrics
1 Week: -1.97%
1 Month: 9.56%
3 Months: -27.08%
6 Months: 51.53%
1 Year: 26.81%
YTD: -27.08%
Company Details
Employees: 48
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.